Literature DB >> 31839647

Investigation of thyroid cancer cases that were not detected in the Thyroid Ultrasound Examination program of the Fukushima Health Management Survey but diagnosed at Fukushima Medical University Hospital.

Susumu Yokoya1, Manabu Iwadate1,2,3, Hiroki Shimura1,3,4, Satoru Suzuki1,3, Takashi Matsuzuka3,5, Satoshi Suzuki1,2,3, Shigeyuki Murono5, Seiji Yasumura3,6, Kenji Kamiya3,7, Yuko Hashimoto8, Shin-Ichi Suzuki1,2.   

Abstract

The Great East Japan Earthquake, which occurred on March 11, 2011, and its subsequent Fukushima Daiichi Nuclear Power Plant accident, prompted implementation of the Thyroid Ultrasound Examination (TUE) program as a part of the Fukushima Health Management Survey. The purpose of this program is to support residents of Fukushima Prefecture, and to analyze the health effects of the released radionuclides. Regardless of relatively high participation rates and a well-planned diagnostic flow, it is conceivable that not all thyroid cancer cases can be detected by the TUE program. The aims of the present study were to identify and characterize these "outside" cases, targeting patients at Fukushima Medical University (FMU) Hospital. As of June 30, 2017, we have successfully identified 11 outside cases. These corresponded to 5.7% of the 194 subjects who were identified as having thyroid cancer or suspected thyroid cancer in the TUE program. Although the outside subjects of other institutes were not investigated, the present study may have identified the majority of outside subjects in Japan, considering that FMU Hospital treats a large number of thyroid cancer subjects. Furthermore, the characteristics of the 11 subjects were not different from those of the subjects identified in the TUE program. These findings confirm that the TUE program was able to identify subjects of thyroid cancer adequately and sufficiently.

Entities:  

Keywords:  Fukushima Daiichi Nuclear Power Plant accident; Fukushima Health Management Survey; thyroid cancer; thyroid ultrasound examination

Year:  2019        PMID: 31839647      PMCID: PMC7012588          DOI: 10.5387/fms.2019-26

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  4 in total

Review 1.  The Bethesda System For Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

2.  Childhood and Adolescent Thyroid Cancer in Fukushima after the Fukushima Daiichi Nuclear Power Plant Accident: 5 Years On.

Authors:  S Suzuki
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-01-25       Impact factor: 4.126

3.  Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.

Authors:  Shunichi Yamashita; Shinichi Suzuki; Satoru Suzuki; Hiroki Shimura; Vladimir Saenko
Journal:  Thyroid       Date:  2017-12-01       Impact factor: 6.568

4.  Study protocol for the Fukushima Health Management Survey.

Authors:  Seiji Yasumura; Mitsuaki Hosoya; Shunichi Yamashita; Kenji Kamiya; Masafumi Abe; Makoto Akashi; Kazunori Kodama; Kotaro Ozasa
Journal:  J Epidemiol       Date:  2012-08-25       Impact factor: 3.211

  4 in total
  1 in total

Review 1.  Demonstrating the undermining of science and health policy after the Fukushima nuclear accident by applying the Toolkit for detecting misused epidemiological methods.

Authors:  Toshihide Tsuda; Yumiko Miyano; Eiji Yamamoto
Journal:  Environ Health       Date:  2022-08-24       Impact factor: 7.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.